Aethlon Medical Inc. of San Diego has formed a relationship with Kentucky Bioprocessing to establish processes that will support Aethlon’s Hemopurifier®, a medical device that absorbs viruses and immunosuppressive particles from the bloodstream. “The relationship with Kentucky Bioprocessing represents an important step towards establishing the long-term commercial feasibility of our Hemopurifier®, said Aethlon Medical CEO Jim Joyce. “Beyond a significant cost reduction of our affinity agents, the relationship offers large-yield production potential in time frames that could improve our response capability against viral outbreaks, including unforeseen bioterror and pandemic threats.”
-
Share This!
Owensboro
November 1, 2009
387 Views
You may also like
Popular Stories
UPS expects cash flow of $17-18B in 2026
March 27, 2024
Coolest Things Made In Ky tourney is at Round of 8
March 28, 2024
S&P Global Market Intelligence recognize Republic Bank
March 27, 2024
NKU public lecture series explores where AI is taking us
March 27, 2024
OP-ED: Confronting Ky food insecurity together
March 27, 2024
The Lane Report
- SCS-2 building $63M metals distribution facility in Bowling Green
- Flooded locales can apply for parts of $297M recovery pool
- U Cumberlands adds supply chain management masters degree
- Bezos Academy to open new tuition-free preschool in Fairdale
- Franklin Precision gets incentives for EV battery component addition
- Still Austin’s Straight Rye Whiskey: Spring Release Bottled in Bond
- Coolest Things Made In Ky tourney is at Round of 8
- EKU, Somerset Community College partner for social work degree
- Diversey OK’d for $2.5M in tax breaks for $97M manufacturing facility
- Bespoken Spirits opens $3.2M headquarters in Lexington
Add Comment